QR-koodi

Disease burden of ATTR amyloidosis based on the SF-36® health survey

Abstract Transthyretin (ATTR) amyloidosis is a progressive systemic disease associated with substantial morbidity and mortality. Although health-related quality of life (HRQoL) assessments are increasingly incorporated into clinical trials, data in ATTR amyloidosis remain limited. We conducted a ret...

Täydet tiedot

Tallennettuna:
Päätekijät: Vaishali Sanchorawala, Alexandra Greatsinger, Andrew Staron, John L. Berk, Lisa M. Mendelson, Tracy Joshi, Natasha J. Burke, Nadia Tabatabaeepour, Jess Smith, James Signorovitch
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2026-04-01
Sarja:Cardio-Oncology
Aiheet:
ATTR amyloidosis
HRQOL
SF-36
Disease burden
Linkit:https://doi.org/10.1186/s40959-026-00482-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia